Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierluigi di Mauro

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|December 16, 2020
Bronchoesophageal FistulaPierluigi di Mauro, Vittorio Ferrari
Journal for Immunotherapy of Cancer|August 25, 2021
Not all hematopoietic growth factors are created equal: should we gain information for their use with immunotherapy?Paolo Bossi, Cristina Gurizzan, Luigi Lorini, et al.
Frontiers in Oncology|August 21, 2024
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case reportElena Fassi, Vito Amoroso, Deborah Cosentini, et al.
Cancers|December 23, 2022
Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: A Systematic Review and Meta-AnalysisMaria Gemelli, Diego Luigi Cortinovis, Alice Baggi, et al.
Cancers|November 25, 2020
Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future ProspectsLorenzo Pilla, Andrea Alberti, Pierluigi Di Mauro, et al.
Frontiers in Oncology|March 9, 2023
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case reportPierluigi di Mauro, Greta Schivardi, Rebecca Pedersini, et al.
Life (Basel, Switzerland)|March 25, 2022
How to Treat HR+/HER2- Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished StoryViola Cogliati, Serena Capici, Francesca Fulvia Pepe, et al.
Journal of Clinical Medicine|November 26, 2022
Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal CancersAndrea Esposito, Erika Stucchi, Maria Baronchelli, et al.
Critical Reviews in Oncology/Hematology|December 5, 2025
Clinical presentation, prognosis, and treatment strategies for thymoma-associated multiorgan autoimmunity: A pooled analysisGiorgia Carola, Vito Amoroso, Deborah Cosentini, et al.
Breast (Edinburgh, Scotland)|October 26, 2022
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapyRebecca Pedersini, Pierluigi di Mauro, Vito Amoroso, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|December 16, 2020
Bronchoesophageal FistulaPierluigi di Mauro, Vittorio Ferrari
Journal for Immunotherapy of Cancer|August 25, 2021
Not all hematopoietic growth factors are created equal: should we gain information for their use with immunotherapy?Paolo Bossi, Cristina Gurizzan, Luigi Lorini, et al.
Frontiers in Oncology|August 21, 2024
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case reportElena Fassi, Vito Amoroso, Deborah Cosentini, et al.
Cancers|December 23, 2022
Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: A Systematic Review and Meta-AnalysisMaria Gemelli, Diego Luigi Cortinovis, Alice Baggi, et al.
Cancers|November 25, 2020
Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future ProspectsLorenzo Pilla, Andrea Alberti, Pierluigi Di Mauro, et al.
Frontiers in Oncology|March 9, 2023
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case reportPierluigi di Mauro, Greta Schivardi, Rebecca Pedersini, et al.
Life (Basel, Switzerland)|March 25, 2022
How to Treat HR+/HER2- Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished StoryViola Cogliati, Serena Capici, Francesca Fulvia Pepe, et al.
Journal of Clinical Medicine|November 26, 2022
Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal CancersAndrea Esposito, Erika Stucchi, Maria Baronchelli, et al.
Critical Reviews in Oncology/Hematology|December 5, 2025
Clinical presentation, prognosis, and treatment strategies for thymoma-associated multiorgan autoimmunity: A pooled analysisGiorgia Carola, Vito Amoroso, Deborah Cosentini, et al.
Breast (Edinburgh, Scotland)|October 26, 2022
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapyRebecca Pedersini, Pierluigi di Mauro, Vito Amoroso, et al.
Pageof 3